Free Trial

Genus (GNS) Competitors

Genus logo
GBX 2,017.10 +19.10 (+0.96%)
As of 05:06 AM Eastern

GNS vs. HWDN, DPH, IGG, CTY, SMWH, CAR, PRP, AUK, STG, and BAY

Should you be buying Genus stock or one of its competitors? The main competitors of Genus include Howden Joinery Group (HWDN), Dechra Pharmaceuticals (DPH), IG Group (IGG), City of London (CTY), WH Smith (SMWH), Carclo (CAR), Prime People (PRP), Aukett Swanke Group (AUK), Strip Tinning (STG), and Bay Capital (BAY). These companies are all part of the "personal services" industry.

Genus vs. Its Competitors

Genus (LON:GNS) and Howden Joinery Group (LON:HWDN) are both personal services companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

Howden Joinery Group has a net margin of 10.82% compared to Genus' net margin of 1.18%. Howden Joinery Group's return on equity of 25.70% beat Genus' return on equity.

Company Net Margins Return on Equity Return on Assets
Genus1.18% 1.41% 3.31%
Howden Joinery Group 10.82%25.70%10.70%

Genus pays an annual dividend of GBX 32 per share and has a dividend yield of 1.6%. Howden Joinery Group pays an annual dividend of GBX 21 per share and has a dividend yield of 2.5%. Genus pays out 265.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Howden Joinery Group pays out 45.0% of its earnings in the form of a dividend. Howden Joinery Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Howden Joinery Group has higher revenue and earnings than Genus. Howden Joinery Group is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genus£666.67M1.98£7.87M£12.06167.20
Howden Joinery Group£2.34B1.97£253.42M£46.6518.12

Genus has a beta of 0.37, meaning that its share price is 63% less volatile than the S&P 500. Comparatively, Howden Joinery Group has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500.

In the previous week, Howden Joinery Group had 5 more articles in the media than Genus. MarketBeat recorded 6 mentions for Howden Joinery Group and 1 mentions for Genus. Howden Joinery Group's average media sentiment score of 0.12 beat Genus' score of 0.00 indicating that Howden Joinery Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Genus
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Howden Joinery Group
0 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

77.8% of Genus shares are held by institutional investors. Comparatively, 70.6% of Howden Joinery Group shares are held by institutional investors. 0.8% of Genus shares are held by company insiders. Comparatively, 0.5% of Howden Joinery Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Genus currently has a consensus target price of GBX 2,150, indicating a potential upside of 6.59%. Howden Joinery Group has a consensus target price of GBX 971.33, indicating a potential upside of 14.88%. Given Howden Joinery Group's higher possible upside, analysts plainly believe Howden Joinery Group is more favorable than Genus.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Genus
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Howden Joinery Group
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

Howden Joinery Group beats Genus on 12 of the 17 factors compared between the two stocks.

Get Genus News Delivered to You Automatically

Sign up to receive the latest news and ratings for GNS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GNS vs. The Competition

MetricGenusBiotechnology IndustryMedical SectorLON Exchange
Market Cap£1.32B£125.79M£5.54B£2.96B
Dividend Yield1.69%3.74%5.39%5.02%
P/E Ratio167.203.2926.17144.10
Price / Sales1.983,921.79413.55257,096.93
Price / Cash50.5613.1936.1327.97
Price / Book2.4442.928.025.29
Net Income£7.87M-£92.79M£3.15B£5.90B
7 Day Performance2.60%0.60%1.48%0.23%
1 Month Performance2.43%1.80%3.66%4.86%
1 Year Performance17.82%177.02%34.68%80.47%

Genus Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GNS
Genus
0.3547 of 5 stars
GBX 2,017.10
+1.0%
GBX 2,150
+6.6%
+22.6%£1.32B£666.67M167.20480Positive News
HWDN
Howden Joinery Group
2.539 of 5 stars
GBX 856
-1.6%
GBX 971.33
+13.5%
-4.1%£4.67B£2.34B18.3512,000
DPH
Dechra Pharmaceuticals
N/AN/AN/AN/A£4.40B£761.50M-15,464.002,457
IGG
IG Group
3.0568 of 5 stars
GBX 1,064.09
-0.4%
GBX 1,466
+37.8%
+27.9%£3.77B£913.00M7.102,754News Coverage
Positive News
CTY
City of London
N/AGBX 487.54
-0.5%
N/A+16.3%£2.41B£307.08M8.21N/ADividend Announcement
SMWH
WH Smith
3.6602 of 5 stars
GBX 1,059.47
-6.2%
GBX 1,430
+35.0%
-3.5%£1.36B£1.83B21.8614,935Dividend Increase
Gap Down
CAR
Carclo
N/AGBX 49
+7.2%
N/A+142.1%£35.97M£132.66M-10.911,059
PRP
Prime People
N/AN/AN/AN/A£8.15M£19.72M10.9813,100Gap Down
AUK
Aukett Swanke Group
N/AN/AN/AN/A£5.46M£23.61M-6.3232,200Positive News
Gap Down
STG
Strip Tinning
N/AGBX 27.30
-0.7%
N/A-48.0%£4.98M£10.09M-1.664,060Gap Down
BAY
Bay Capital
N/AGBX 5.50
-9.1%
N/A-16.5%£3.85MN/A-2.712Gap Down

Related Companies and Tools


This page (LON:GNS) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners